Compare HFRO & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HFRO | SMTI |
|---|---|---|
| Founded | 2000 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 355.6M | 322.2M |
| IPO Year | 2017 | 2008 |
| Metric | HFRO | SMTI |
|---|---|---|
| Price | $5.21 | $32.79 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 181.4K | 56.1K |
| Earning Date | 01-01-0001 | 11-12-2026 |
| Dividend Yield | ★ 8.87% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | N/A | $11.81 |
| Revenue Next Year | N/A | $12.75 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $4.79 | $16.05 |
| 52 Week High | $7.74 | $35.52 |
| Indicator | HFRO | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 26.61 | 48.44 |
| Support Level | N/A | $30.40 |
| Resistance Level | $6.49 | $34.01 |
| Average True Range (ATR) | 0.24 | 1.00 |
| MACD | -0.09 | 0.16 |
| Stochastic Oscillator | 18.64 | 86.67 |
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.